These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20823283)

  • 1. Mutational analysis of flucytosine resistance in Candida glabrata.
    Edlind TD; Katiyar SK
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4733-8. PubMed ID: 20823283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.
    Florent M; Noël T; Ruprich-Robert G; Da Silva B; Fitton-Ouhabi V; Chastin C; Papon N; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2982-90. PubMed ID: 19414575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway.
    Vu K; Thompson GR; Roe CC; Sykes JE; Dreibe EM; Lockhart SR; Meyer W; Engelthaler DM; Gelli A
    Med Mycol; 2018 Oct; 56(7):857-867. PubMed ID: 29554336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
    Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.
    Chapeland-Leclerc F; Bouchoux J; Goumar A; Chastin C; Villard J; Noël T
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3101-8. PubMed ID: 16048910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.
    Vandeputte P; Pineau L; Larcher G; Noel T; Brèthes D; Chabasse D; Bouchara JP
    Mycopathologia; 2011 Jan; 171(1):11-21. PubMed ID: 20617462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
    Chapeland-Leclerc F; Hennequin C; Papon N; Noël T; Girard A; Socié G; Ribaud P; Lacroix C
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1360-2. PubMed ID: 20038613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.
    McManus BA; Moran GP; Higgins JA; Sullivan DJ; Coleman DC
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4678-85. PubMed ID: 19704126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.
    Dodgson AR; Dodgson KJ; Pujol C; Pfaller MA; Soll DR
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2223-7. PubMed ID: 15155225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus.
    Billmyre RB; Applen Clancey S; Li LX; Doering TL; Heitman J
    Nat Commun; 2020 Jan; 11(1):127. PubMed ID: 31913284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast.
    Paluszynski JP; Klassen R; Meinhardt F
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae.
    Hartzog PE; Nicholson BP; McCusker JH
    Yeast; 2005 Jul; 22(10):789-98. PubMed ID: 16088873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Mutational Frequency and
    Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland.
    Szweda P; Gucwa K; Romanowska E; Dzierz Anowska-Fangrat K; Naumiuk Ł; Brillowska-Da Browska A; Wojciechowska-Koszko I; Milewski S
    J Med Microbiol; 2015 Jun; 64(6):610-619. PubMed ID: 25818698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.